Collecting this in one place because it comes up every few weeks and the answer is always assembled from scratch. It is about thyroid monitoring, and it is deliberately narrow — everything I am not confident about is marked as such.
What is actually established
Routine calcitonin screening is not recommended and does more harm than good in this population — the false-positive rate is high and the workup is invasive. The rodent medullary thyroid carcinoma signal that drives the labelling has not translated into a human signal, but a personal or family history of MTC or MEN2 is a genuine contraindication rather than a formality. Separately, TSH is worth having at baseline because hypothyroidism explains fatigue that people will otherwise blame on the drug.
The condition it depends on
The caveat that a nodule found incidentally still needs following up on its own merits.
The practical version
Baseline worth having: TSH, and free T4 if TSH is abnormal. Calcitonin only if there is an actual MTC or MEN2 history.
What I am not sure about
What I am trying to establish is why calcitonin screening is not recommended when the label carries a thyroid warning, because those two facts look contradictory from the outside. Tell me what I have not thought of.
Dr.Martinez said:Routine calcitonin screening is not recommended and does more harm than good in this population — the false-positive rate is high and the workup is…
Thyroid cancer screening labs for thyroid monitoring — addressing the boxed warning concern with actual data:
Calcitonin level: 4.0 pg/mL (normal <10). Checked at baseline, month 6, and month 12. Rock stable, no upward trend.
Thyroid ultrasound: normal, no nodules at month 12.
The MTC risk from rodent studies has not been confirmed in human post-marketing data across millions of patient-years. The boxed warning is a regulatory precaution based on animal data. While monitoring is prudent, the clinical risk appears to be negligible.
Dr.Martinez said:Routine calcitonin screening is not recommended and does more harm than good in this population — the false-positive rate is high and the workup is…
I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsThis one has a reasonably settled answer, so here it is. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.
SarahChen_PharmD said:Thyroid cancer screening labs for thyroid monitoring — addressing the boxed warning concern with actual data: Calcitonin level: 4.0 pg/mL (normal…
Same pattern here, and in the same order. The detail I would add is minor and it is already implied above.